Search Results

Effect of a single-dose denosumab on mineral homeostasis in infertile men: insights from a pilot intervention study and a randomized controlled trial.

• Authors : Yahyavi, Sam Kafai^1,2 (AUTHOR); Holt, Rune¹ (AUTHOR); Juel Mortensen, Li^2,3 (AUTHOR)

• Source: BMC Medicine. 3/7/2025, Vol. 23 Issue 1, p1-11. 11p.

Record details

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study.

• Authors : Zheng M; Osteoporosis Clinical Center, The Second Affiliated Hospital of Soochow University, Suzhou, China.; Wang XY

Subjects: Denosumab*/Denosumab*/Denosumab*/therapeutic use ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/physiopathology

• Source: Orthopaedic surgery [Orthop Surg] 2025 Jun; Vol. 17 (6), pp. 1644-1655. Date of Electronic Publication: 2025 Apr 02.Publisher: Wiley on behalf of the Chinese Orthopedic Association Country of Publication: Australia NLM ID: 101501666 Publication Model: Print-Electronic

Record details

Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis.

• Authors : Ribes S; Global Clinical Development, Hexal AG (a Sandoz Company), Holzkirchen, Germany. .; Krivtsova N

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Denosumab*/Denosumab*/Denosumab*/therapeutic use ; Denosumab*/Denosumab*/Denosumab*/immunology

• Source: Drugs in R&D [Drugs R D] 2025 Jun; Vol. 25 (2), pp. 141-152. Date of Electronic Publication: 2025 May 23.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Efficacy of denosumab in treatment of osteoporosis in patients with rheumatoid arthritis: a meta-analysis of randomized controlled trial.

• Authors : Tang T; Department of Orthopedics, The First People's Hospital of Jiashan, Jiaxing, Zhejiang Province, China.; Wan B

Subjects: Denosumab*/Denosumab*/Denosumab*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/complications

• Source: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2025 May 07; Vol. 26 (1), pp. 450. Date of Electronic Publication: 2025 May 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474

Record details

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

• Source: Effects of Cycle Therapy With Romosozumab and Denosumab 2 Years vs 1 Year Romosozumab Followed by 1 Year Denosumab in Postmenopausal

Record details

A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status

• Authors : Xiujuan Qu, Chief Physician

• Source: A Phase II Single-Arm Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small

Record details

A Multicenter Study by the DENO Research Group on the Use of Denosumab in Giant-Cell Tumors of the Bone.

• Authors : Calva, Carolina de la¹ (AUTHOR) ; Angulo, Manuel^1,2 (AUTHOR); González-Rojo, Paula^1,3 (AUTHOR)

• Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 9, p3242. 13p.

Record details

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

• Source: An Open-label, Multi-center, Phase 4 Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Record details

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

• Authors : Radius Health, Inc.; Crozer-Keystone Health System; Joseph Lane, MD, Principal Investigator

• Source: Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab AloneLeder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM,

Record details

EVALUATION OF THE EFFICACY OF SYSTEMICALLY APPLIED DENOSUMAB IN THE REPAIR OF BONE DEFECTS.

• Authors : PİRİNÇ, Ömer¹; ALAN, Hilal²; GÜL, Mehmet³

• Source: Journal of Inonu University Health Services Vocational School / İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi. 2025, Vol. 13 Issue 2, p265-280. 16p.

Record details